TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Carmel Pharma AB
Closing information (x1000 EUR)
Closing information | 2022/09 | 2021/09 | 2020/09 |
Turnover | 6,236 | 5,535 | 6,216 |
Financial expenses | 0 | 1 | 0 |
Earnings before taxes | 6,240 | 5,706 | 6,387 |
EBITDA | 6,132 | 5,400 | |
Total assets | 45,118 | 41,655 | 40,833 |
Current assets | 1,428 | 2,158 | 40,833 |
Current liabilities | 11,397 | 39 | 37 |
Equity capital | 33,721 | 36,099 | 34,658 |
- share capital | 812 | 869 | 841 |
Employees (average) | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2022/09 | 2021/09 | 2020/09 |
Solvency | 74.7% | 86.7% | 84.9% |
Turnover per employee | |||
Profit as a percentage of turnover | 100.1% | 103.1% | 102.8% |
Return on assets (ROA) | 13.8% | 13.7% | 15.6% |
Current ratio | 12.5% | 5533.3% | 110359.5% |
Return on equity (ROE) | 18.5% | 15.8% | 18.4% |
Change turnover | 1,064 | -888 | 618 |
Change turnover % | 21% | -14% | 11% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/09 | 2021/09 | 2020/09 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.